Agile Therapeutics Cash on Hand 2013-2023 | AGRX

Agile Therapeutics cash on hand from 2013 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Agile Therapeutics Annual Cash on Hand
(Millions of US $)
2023 $3
2022 $5
2021 $19
2020 $54
2019 $34
2018 $8
2017 $36
2016 $49
2015 $34
2014 $40
2013 $2
2012 $20
Agile Therapeutics Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $3
2023-09-30 $3
2023-06-30 $3
2023-03-31 $4
2022-12-31 $5
2022-09-30 $6
2022-06-30 $13
2022-03-31 $4
2021-12-31 $19
2021-09-30 $15
2021-06-30 $31
2021-03-31 $40
2020-12-31 $54
2020-09-30 $72
2020-06-30 $87
2020-03-31 $94
2019-12-31 $34
2019-09-30 $18
2019-06-30 $11
2019-03-31 $12
2018-12-31 $8
2018-09-30 $17
2018-06-30 $22
2018-03-31 $28
2017-12-31 $36
2017-09-30 $44
2017-06-30 $34
2017-03-31 $42
2016-12-31 $49
2016-09-30 $52
2016-06-30 $59
2016-03-31 $65
2015-12-31 $34
2015-09-30 $39
2015-06-30 $46
2015-03-31 $54
2014-12-31 $40
2014-09-30 $46
2014-06-30 $53
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2012-12-31 $20
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.003B $0.020B
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.785B 5.70
Dr Reddy's Laboratories (RDY) India $12.479B 19.73
BridgeBio Pharma (BBIO) United States $5.191B 0.00
Aspen Pharmacare (APNHY) South Africa $5.181B 0.00
Bausch Health Cos (BHC) Canada $2.956B 2.26
Amphastar Pharmaceuticals (AMPH) United States $2.052B 14.27
Supernus Pharmaceuticals (SUPN) United States $1.664B 0.00
Taysha Gene Therapies (TSHA) United States $0.483B 0.00
Generation Bio (GBIO) United States $0.207B 0.00
Personalis (PSNL) United States $0.081B 0.00
Assembly Biosciences (ASMB) United States $0.070B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00